Sat.Mar 19, 2022 - Fri.Mar 25, 2022

article thumbnail

The Digital Health Start-up Journey: Series A to scale-up

pharmaphorum

Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find. The growth of a start-up after obtaining Series A funding is a transformational phase when scaling up the company becomes critical. The CEO can experience pressure to deliver on the revenue growth goals, whilst still developing their product, growing the team, and implementing core processes for the company.

Hospitals 145
article thumbnail

UK’s first digital health training programme for all NHS frontline staff

Pharma Times

The platform to build a digital-ready frontline workforce will be available to all NHS and social care staff

153
153
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2 Strategies to Grow Your Excipient Business by Tracking Drug Patents

Drug Patent Watch

Drugs contain ingredients with therapeutic activity, so-called “active ingredients” as well as inactive ingredients. These inactive ingredients, called excipients, are included in oral products for various reasons, such as to…. The post 2 Strategies to Grow Your Excipient Business by Tracking Drug Patents appeared first on DrugPatentWatch - Make Better Decisions.

105
105
article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. But one key member is often omitted: the patient’s caregiver. With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. Although the caregiver is seen as an extension of the patient and their role is not strictly defined, they are informal members of the front-line care team.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Virtual and augmented reality: Bringing the future to pharma manufacturing

pharmaphorum

Virtual and augmented reality tools have reached a level of maturity to be utilised across various industries. In this article, Ben Hargreaves asks whether there is particular potential for the technologies to revolutionise staff training and reduce costs in pharma manufacturing. Virtual reality (VR) and augmented reality (AR) have spent a lot of time in the headlines recently.

article thumbnail

NHS fast-tracks new targeted drug for rare lung cancer

Pharma Times

Patients eligible to receive Takeda’s Exkivity (mobocertinib) have a rare form of lung cancer that cannot be removed by surgery

137
137

More Trending

article thumbnail

AstraZeneca, Merck breast cancer treatment lands FDA approval

Outsourcing Pharma

The agency has approved Lynparza for use in the US as an adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer.

103
103
article thumbnail

Google seeks FDA nod for passive AFib detection with Fitbit

pharmaphorum

Tech giant Google has filed for FDA approval to use its Fitbit wearable to help detect atrial fibrillation (AFib), a common heart abnormality that raises the risk of heart attack, stroke and sudden death. Fitbit is already approved by the FDA to provide electrocardiogram (ECG) monitoring of heart rhythms, and in 2020 its Sense Smartwatch was cleared by the regulator to use the ECG functionality to detect AFib – although that requires active input from the user.

119
119
article thumbnail

Jazz Pharmaceuticals reveals new manufacturing facility for cannabis-based medicines

Pharma Times

The site in Kent will support the manufacture of regulatory approved cannabis-based medicines while also leveraging environmental practices

112
112
article thumbnail

Moderna to Seek Authorization of Its Coronavirus Vaccine for Young Children

NY Times

The company said the vaccine produced a strong immune response in children younger than 6, but proved only about 40 percent effective in preventing symptomatic Covid-19.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Janssen initiates psoriasis trial to bridge racial gaps in care

Outsourcing Pharma

The pharmaceutical company's clinical study is intended to examine critical gaps in care for people of color living with moderate to severe plaque psoriasis.

article thumbnail

Pharma’s ambition in connected health not yet matched by execution

pharmaphorum

Four out of five biopharma companies think that the market opportunity for connected health products exceeds their traditional drug business, but adoption remains low, with only 20% of use cases at present going beyond proof of concept. That’s one of the conclusions of a new study by Capgemini, which suggests that the number of approved connected health offerings – digital health products and services including wearables, digital therapeutics and software-as-a-medical-device (SaMD) – will

119
119
article thumbnail

Poolbeg signs AI deal to advance human challenge data

Pharma Times

Collaboration will focus on AI analysis of flu progression, immune responses and the development of new vaccines

article thumbnail

Which pharmaceutical companies have the most drug patents in Slovakia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Slovakia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Slovakia? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Pancreatic cancer organization adds new clinical trial sites

Outsourcing Pharma

The Pancreatic Cancer Action Network has engaged five new clinical trial sites in the US, which will aid in evaluation of Novartisâ investigational therapy.

95
article thumbnail

The efficacy of Mental Health Apps

pharmaphorum

In January, PLOS Digital Health published a study which claimed that there’s “sparse” data to support the efficacy of most mental health apps. In their meta-analysis of published studies, the authors found universal deficiencies and concluded that there’s no convincing evidence that app-based interventions deliver meaningful outcomes. Without digging further, one might think the current case for digital therapeutics is weak.

114
114
article thumbnail

Stalicla completes phase 1b trials into precision medicine for autism spectrum disorder

Pharma Times

STP1 has demonstrated good safety and tolerability profiles, while also showing positive results for neurological function

109
109
article thumbnail

Warped Incentives Update: The Gross-to-Net Bubble Exceeded $200 Billion in 2021

Drug Channels

Time for Drug Channels Institute’s annual update on the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs' list prices and their sales at net prices after rebates and other reductions. We estimate that the gross-to-net bubble reached $204 billion for patent-protected brand-name drugs in 2021. If we include brand-name drugs that have lost patent protection and face competition from generic equivalents, the bubble was even higher, at $236 billion.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

F.D.A.’s Accelerated Drug Approvals Come Under Scrutiny

NY Times

A drug to prevent preterm birth may provide the next test of the agency’s process for speedily getting drugs on the market, despite limited evidence that some work.

58
article thumbnail

AI tool helps detect leprosy using pictures

pharmaphorum

Ann Aerts, head of the Novartis Foundation, tells us about AI4Leprosy, a diagnostic assistant researchers developed that helps healthcare workers detect leprosy with over 90% accuracy using pictures of a patient’s skin lesion. . Leprosy has existed for more than 3,000 years and is the one of the oldest diseases known to humanity. Though a cure is available, 200,000 individuals are still diagnosed with the disease each year. “We’ve managed to reduce the burden of leprosy by 95%

110
110
article thumbnail

Huma and AstraZeneca collaborate to advance digital innovation

Pharma Times

Digital-first patient care is a priority as the companies join forces to improve patients' lives

109
109
article thumbnail

Ukraine war dramatically impacting global clinical development: Phesi

Outsourcing Pharma

The companyâs analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the countryâs borders.

59
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

The Evolving Medical Benefits Landscape—Are you Ready for It?

Drug Channels

Today’s guest post comes from Ian Ocilka, Senior VP of Client Solutions at ConnectiveRx. Ian explains some of the challenges associated with negotiating the medical benefit for both patients and providers. He goes on to describe the need for combining technology solutions and meaningful human connection for improved patient outcomes. To learn more, join experts from ConnectiveRx on April 26th at 1 pm ET for a free, online panel discussion: The Evolving Medical Benefits Landscape—Are you Ready fo

article thumbnail

Is your digital communication strategy up to par?

pharmaphorum

Whether you’re a large pharma company or a small, emerging one, communication is key. Success or failure hinges on communicating the advantages of your offerings to both prescribing providers and patients. Join us on Tuesday 12 th April at 13:00 BST / 14:00 CET / 8:00 am EDT as panelists lay out how a better approach to communication can lead to improved patient outcomes, preventing drop-off rates, better predicting product forecasts, increasing script volume, integrating localised digital strat

article thumbnail

Takeda’s Exkivity receives MHRA conditional marketing authorisation

Pharma Times

Approval of Exkivity could mean NHS access to ground-breaking treatment for patients with rare lung cancer

103
103
article thumbnail

Which drugs have supplementary protection certificates in the most countries?

Drug Patent Watch

This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…. The post Which drugs have supplementary protection certificates in the most countries? appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

New 2022 Rates Position CMS’ Chronic Care Programs Are Ripe for Increased Revenue, Improved Outcomes

PharmD Live

If you’ve implemented chronic care management (CCM) or remote physiologic monitoring (RPM, a.k.a. remote patient monitoring) in your practice, you know that they generate new streams of revenue while allocating more time to take better care of your patients—with potentially life-saving results. In fact, Medicare is so confident that these programs will pay off that it has dramatically increased CCM overall reimbursement rates for 2022.

52
article thumbnail

NHS grants fast-track access to Takeda’s lung cancer drug Exkivity

pharmaphorum

Takeda has secured UK approval for its lung cancer therapy Exkivity, with an NHS access deal that could see it prescribed to patients within the next few weeks. The Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional marketing authorisation to Exkivity (mobocertinib) as a monotherapy for non-small-cell lung cancer (NSCLC) patients whose tumours have EGFR exon20 insertion mutations, after first-line chemotherapy.

article thumbnail

NICE recommends Biomarin’s Vimizim for patients with rare life-limiting metabolic disorder

Pharma Times

Patients with a life-limiting skeletal condition welcome availability of elosulfase alfa on the NHS

103
103
article thumbnail

New patent for Zogenix Inc drug FINTEPLA

Drug Patent Watch

Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are eleven patents…. The post New patent for Zogenix Inc drug FINTEPLA appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

[ Save Your Seat ] PMN: Direct to Consumer (DTC) Engagement Summit

Pharma Marketing Network

REGISTER HERE. Join PMN and industry marketing experts on April 28th at 12PM EST , to learn more about how to elevate your patient engagement marketing. Panels include: Effective Use of Data in DTC Marketing. There is no question that data is the path to better understanding your audience, but what data points are most important? What’s useful, and what’s misleading?

52